Cite
HARVARD Citation
Moreau, P. et al. (2021). Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial. Lancet oncology. 22 (10), pp. 1378-1390. [Online].